Serum N-Desmethylcitalopram Concentrations are Associated with the Clinical Response to Citalopram of Patients with Major Depression

Creative Commons License

ÖZBEY G., Yücel B., BODUR N. E., TAYCAN S. E., ARSLAN T., CERIT N., ...Daha Fazla

PSYCHIATRY INVESTIGATION, cilt.15, sa.3, ss.313-319, 2018 (SCI-Expanded, SSCI, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15 Sayı: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.30773/pi.2017.05.22
  • Dergi Adı: PSYCHIATRY INVESTIGATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
  • Sayfa Sayıları: ss.313-319
  • Anahtar Kelimeler: Serum concentration, Citalopram, N-desmethylcitalopram, Efficacy, Tolerability, Major depression, ANTIDEPRESSANT DRUGS, METABOLITES, POPULATION, PSYCHIATRY, INHIBITORS
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Objective Citalopram (CITA) is a widely used and well-tolerated selective serotonin reuptake inhibitor. The aim of the study was to evaluate the possible influences of serum concentrations of CITA and its major metabolite n-desmethylcitalopram (NDCITA) on the efficacy and tolerability of CITA in patients with major depressive disorder.